Insights

Expansion Opportunities BioVectra has recently expanded its facilities to Nova Scotia and opened a new 36,000 square-foot facility, presenting potential sales opportunities for suppliers of construction materials, laboratory equipment, and facility maintenance services.

Leadership Award Recognition BioVectra received the 2025 CDMO Leadership Award for biologics, indicating industry recognition and potential partnerships with companies interested in collaborating with award-winning organizations.

Acquisition by H.I.G. Capital Being acquired by H.I.G. Capital has positioned BioVectra as an independent entity, potentially creating opportunities for partnerships, collaborations, and new business ventures under its new ownership structure.

Talent Acquisition Growth With the addition of Normand Blais as Senior Director, Development & Innovation, Biologics, BioVectra showcases a focus on talent acquisition, suggesting potential collaborations with experts in biologics research and development.

Government Investment Impact BioVectra's collaboration with federal and provincial governments to build mRNA vaccine production facilities resulting in new job creation presents opportunities for partnerships with suppliers of biomanufacturing equipment, technology, and services.

BIOVECTRA Tech Stack

BIOVECTRA uses 8 technology products and services including Fusion Ads, SAP, Salesforce Marketing Cloud Account Engagement, and more. Explore BIOVECTRA's tech stack below.

  • Fusion Ads
    Advertising
  • SAP
    Customer Relationship Management
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • PHP
    Programming Languages
  • Timesheets
    Time Tracking
  • HTTP/3
    Web & Portal Technology
  • Autoptimize
    Web Platform Extensions
  • Twitter
    Widgets

Media & News

BIOVECTRA's Email Address Formats

BIOVECTRA uses at least 1 format(s):
BIOVECTRA Email FormatsExamplePercentage
FLast@biovectra.comJDoe@biovectra.com
97%
FiLast@biovectra.comJoDoe@biovectra.com
1%
FMiddleLast@biovectra.comJMichaelDoe@biovectra.com
1%
LFirst@biovectra.comDJohn@biovectra.com
1%

Frequently Asked Questions

Where is BIOVECTRA's headquarters located?

Minus sign iconPlus sign icon
BIOVECTRA's main headquarters is located at 11 Aviation Avenue Charlottetown , PE C1e 0A1 CA. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is BIOVECTRA's phone number?

Minus sign iconPlus sign icon
You can contact BIOVECTRA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BIOVECTRA's official website and social media links?

Minus sign iconPlus sign icon
BIOVECTRA's official website is biovectra.com and has social profiles on LinkedIn.

How much revenue does BIOVECTRA generate?

Minus sign iconPlus sign icon
As of April 2025, BIOVECTRA's annual revenue reached $750M.

What is BIOVECTRA's SIC code NAICS code?

Minus sign iconPlus sign icon
BIOVECTRA's SIC code is 5169 - Chemicals and Allied Products, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIOVECTRA have currently?

Minus sign iconPlus sign icon
As of April 2025, BIOVECTRA has approximately 577 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer: P. E.Chief Operating Officer: T. D.Chief Commercial Officer: H. D.. Explore BIOVECTRA's employee directory with LeadIQ.

What industry does BIOVECTRA belong to?

Minus sign iconPlus sign icon
BIOVECTRA operates in the Biotechnology Research industry.

What technology does BIOVECTRA use?

Minus sign iconPlus sign icon
BIOVECTRA's tech stack includes Fusion AdsSAPSalesforce Marketing Cloud Account EngagementPHPTimesheetsHTTP/3AutoptimizeTwitter.

What is BIOVECTRA's email format?

Minus sign iconPlus sign icon
BIOVECTRA's email format typically follows the pattern of . Find more BIOVECTRA email formats with LeadIQ.

How much funding has BIOVECTRA raised to date?

Minus sign iconPlus sign icon
As of April 2025, BIOVECTRA has raised $40M in funding. The last funding round occurred on Mar 03, 2019 for $38M.

When was BIOVECTRA founded?

Minus sign iconPlus sign icon
BIOVECTRA was founded in 1970.
BIOVECTRA

BIOVECTRA

Biotechnology ResearchPrince Edward Island, Canada501-1000 Employees

Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization.

We are a forward-thinking, North American CDMO Pharmaceutical company  specializing in clinical-to-commercial scale production capabilities for:
Biologics
Synthetic small molecules 
Fermented small molecules
Highly potent APIs
Bioreagents
mRNA, pDNA, LNP manufacturing
Fill/Finish

Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.

Section iconCompany Overview

Headquarters
11 Aviation Avenue Charlottetown , PE C1e 0A1 CA
Phone number
SIC Code
5169 - Chemicals and Allied Products, Not Elsewhere Classified
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1970
Employees
501-1000

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $100M$1B

    BIOVECTRA's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $100M$1B

    BIOVECTRA's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.